Newsy's Latest Health News

Dr. Anthony Fauci informed the BBC that the U.S. will determine the safety and efficacy of the COVID-19 vaccine by late November or early December. However, widespread availability is expected several months into 2021, with healthcare workers and high-risk individuals prioritized for initial doses. Public health measures like mask-wearing and social distancing will remain necessary. AstraZeneca has resumed its phase three vaccine trials in the U.S. after FDA safety reviews, and Johnson & Johnson is also preparing to resume its trials. Special thanks were given to Kaiser Health News for their contributions.

When does Dr. Fauci expect the COVID-19 vaccine to be deemed safe and effective?

• By the end of December

• By mid-December

• By the end of November or early December

• By the end of October

Who is likely to receive the first doses of the COVID-19 vaccine according to Dr. Fauci?

• Politicians

• Healthcare workers and high-risk individuals

• Elderly people

• Children

Why were AstraZeneca's vaccine trials paused?

• Due to a lack of funding

• Because of an unexplained illness in a participant

• Due to regulatory issues

• Because of a shortage of volunteers

What did the FDA conclude about AstraZeneca's vaccine trials?

• They should be conducted in another country

• They were unsafe to continue

• They needed more data

• They were safe to resume

Which company announced the resumption of its COVID-19 vaccine trials alongside AstraZeneca?

• Novavax

• Johnson & Johnson

• Moderna

• Pfizer